Shares of Robinhood Markets, Inc. (NASDAQ:HOOD) rose sharply in pre-market trading.

S&P Dow Jones Indices announced a sweeping update to its benchmarks late Friday, unveiling new additions to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600. Robinhood will replace Caesars Entertainment Inc. (NASD: CZR) in the S&P 500, effective prior to the open of trading on Monday, Sept. 22.

Robinhood shares jumped 7.4% to $108.77 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• Eightco Holdings Inc. (NASDAQ:OCTO) shares gained 142.1% to $3.51 in pre-market trading.
• Gyrodyne, LLC (NASDAQ:GYRO) rose 82.1% to $19.48 in pre-market trading.
• Forward Industries, Inc. (NASDAQ:FORD) gained 78.8% to $29.29 in pre-market trading after gaining 10% on Friday.
• Pintec Technology Holdings Limited (NASDAQ:PT) rose 62.1% to $1.54 in pre-market trading. PINTEC announced a private placement of Class A ordinary shares in exchange of ordinary shares of ZIITECH PTY LTD.
• CDT Equity Inc. (NASDAQ:CDT) rose 45.7% to $1.72 n pre-market trading.
• Seres Therapeutics, Inc. (NASDAQ:MCRB) gained 44.8% to $28.05 in pre-market trading.
• Microbot Medical Inc. (NASDAQ:MBOT) jumped 27.3% to $4.66 in pre-market trading after gaining 9% on Friday.
• Acrivon Therapeutics, Inc. (NASDAQ:ACRV) gained 27.8% to $1.70 in pre-market trading.
• Rapport Therapeutics, Inc. (NASDAQ:RAPP) surged 26.3% to $18.13 in pre-market trading. Rapport Therapeutics will announce topline results for RAP-219 Phase 2a trial in focal onset seizures on Monday, Sept. 8.

Losers

• Citius Oncology, Inc. (NASDAQ:CTOR) dipped 25% to $1.41 in pre-market trading.
• MEI Pharma, Inc. (NASDAQ:MEIP) fell 19.3% to $3.42 in pre-market trading.
• CNFinance Holdings Limited (NYSE:CNF) fell 18.8% to $3.78 in pre-market trading after jumping 94% on Friday.
• New Era Energy & Digital, Inc. (NASDAQ:NUAI) shares dipped 17.3% to $0.3111 in pre-market trading after declining 7% on Friday.
• Summit Therapeutics Inc. (NASDAQ:SMMT) declined 17% to $21.57 in pre-market trading after the company announced the updated overall survival results from the Global Phase 3 HARMONi clinical trial of Ivonescimab in EGFR-mutated non-squamous non-small cell lung cancer.
• Twin Vee Powercats Co. (NASDAQ:VEEE) fell 15.3% to $2.40 in pre-market trading after jumping 46% on Friday.
• iSpecimen Inc. (NASDAQ:ISPC) fell 15% to $0.7262 in pre-market trading. iSpecimen shares surged 27% on Friday after the company announced it advanced its $200 million Solana-based digital asset strategy.
• Sono Group N.V. (NASDAQ:SSM) declined 15% to $12.30 in pre-market trading after dipping 34% on Friday. Sono Group announced Nasdaq uplisting approval.
• New Fortress Energy Inc. (NASDAQ:NFE) dipped 12.5% to $2.14 in pre-market trading following second-quarter results.
• Verb Technology Company, Inc. (NASDAQ:TONX) fell 11.9% to $9.45 in the pre-market trading.

Now Read This:

• Top 2 Health Care Stocks That May Plunge This Month

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.